

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.98416628 |
| 2 | regulation of platelet aggregation (GO:0090330) | 5.48422561 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.43367316 |
| 4 | vocalization behavior (GO:0071625) | 5.00984100 |
| 5 | platelet aggregation (GO:0070527) | 4.95098252 |
| 6 | regulation of platelet activation (GO:0010543) | 4.76770776 |
| 7 | protein neddylation (GO:0045116) | 4.68751775 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 4.63028622 |
| 9 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.59604188 |
| 10 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.52612246 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.48673860 |
| 12 | adenosine receptor signaling pathway (GO:0001973) | 4.48380258 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.47029215 |
| 14 | regulation of integrin activation (GO:0033623) | 4.45298240 |
| 15 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.42453954 |
| 16 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.27090392 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.25185423 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.20844698 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.20789383 |
| 20 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.19979243 |
| 21 | megakaryocyte development (GO:0035855) | 4.19933623 |
| 22 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.15058021 |
| 23 | angiogenesis involved in wound healing (GO:0060055) | 4.12054549 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.03688199 |
| 25 | platelet degranulation (GO:0002576) | 3.99042775 |
| 26 | protein localization to synapse (GO:0035418) | 3.97396570 |
| 27 | positive regulation of mast cell activation (GO:0033005) | 3.93420155 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.92941841 |
| 29 | neuronal action potential propagation (GO:0019227) | 3.91156061 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 3.90473717 |
| 31 | response to histamine (GO:0034776) | 3.90118630 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 3.88184143 |
| 33 | negative regulation of norepinephrine secretion (GO:0010700) | 3.88025409 |
| 34 | lipoxygenase pathway (GO:0019372) | 3.87445340 |
| 35 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87404417 |
| 36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.87221104 |
| 37 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.87134593 |
| 38 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.83892009 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 3.83699224 |
| 40 | positive regulation of receptor recycling (GO:0001921) | 3.80235979 |
| 41 | mesodermal cell differentiation (GO:0048333) | 3.79789713 |
| 42 | glutamate secretion (GO:0014047) | 3.73568694 |
| 43 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.73035025 |
| 44 | establishment of skin barrier (GO:0061436) | 3.71374893 |
| 45 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.70351320 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.67966683 |
| 47 | negative regulation of platelet activation (GO:0010544) | 3.66284278 |
| 48 | regulation of lipoprotein metabolic process (GO:0050746) | 3.65296280 |
| 49 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.60827827 |
| 50 | neurotransmitter secretion (GO:0007269) | 3.59874492 |
| 51 | platelet activation (GO:0030168) | 3.58898935 |
| 52 | proline transport (GO:0015824) | 3.57557487 |
| 53 | positive regulation of macrophage differentiation (GO:0045651) | 3.56233571 |
| 54 | neuronal action potential (GO:0019228) | 3.54250949 |
| 55 | homotypic cell-cell adhesion (GO:0034109) | 3.53763685 |
| 56 | hypotonic response (GO:0006971) | 3.53438504 |
| 57 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.52301242 |
| 58 | positive regulation of blood coagulation (GO:0030194) | 3.51281118 |
| 59 | positive regulation of hemostasis (GO:1900048) | 3.51281118 |
| 60 | negative regulation of protein localization to cell surface (GO:2000009) | 3.50802925 |
| 61 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.49601579 |
| 62 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.46868265 |
| 63 | postsynaptic membrane organization (GO:0001941) | 3.44678705 |
| 64 | neutrophil activation (GO:0042119) | 3.44600465 |
| 65 | regulation of synaptic vesicle transport (GO:1902803) | 3.44536415 |
| 66 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.42367450 |
| 67 | negative regulation of dendrite development (GO:2000171) | 3.39476521 |
| 68 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.39046773 |
| 69 | transferrin transport (GO:0033572) | 3.39004536 |
| 70 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.35294064 |
| 71 | startle response (GO:0001964) | 3.34712007 |
| 72 | hepatocyte apoptotic process (GO:0097284) | 3.32567516 |
| 73 | regulation of water loss via skin (GO:0033561) | 3.28021862 |
| 74 | protein localization to cilium (GO:0061512) | 3.27021109 |
| 75 | serotonin receptor signaling pathway (GO:0007210) | 3.25285091 |
| 76 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.23892036 |
| 77 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.23516750 |
| 78 | gamma-aminobutyric acid transport (GO:0015812) | 3.23358569 |
| 79 | long-term synaptic potentiation (GO:0060291) | 3.21982151 |
| 80 | positive regulation of coagulation (GO:0050820) | 3.21287351 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.19988604 |
| 82 | presynaptic membrane organization (GO:0097090) | 3.18767687 |
| 83 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.18388073 |
| 84 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.18310242 |
| 85 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.18310242 |
| 86 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.17745159 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.17745159 |
| 88 | negative regulation of stress fiber assembly (GO:0051497) | 3.17134602 |
| 89 | definitive hemopoiesis (GO:0060216) | 3.16552108 |
| 90 | platelet formation (GO:0030220) | 3.16080990 |
| 91 | regulation of vesicle fusion (GO:0031338) | 3.15778940 |
| 92 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.15495997 |
| 93 | ferric iron transport (GO:0015682) | 3.13698724 |
| 94 | trivalent inorganic cation transport (GO:0072512) | 3.13698724 |
| 95 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.13628498 |
| 96 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.13216831 |
| 97 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.12956842 |
| 98 | neuron recognition (GO:0008038) | 3.12831903 |
| 99 | neurotransmitter transport (GO:0006836) | 3.10775686 |
| 100 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.10521293 |
| 101 | negative regulation of interleukin-17 production (GO:0032700) | 3.10378912 |
| 102 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.09565247 |
| 103 | cyclooxygenase pathway (GO:0019371) | 3.08204258 |
| 104 | detection of calcium ion (GO:0005513) | 3.07520124 |
| 105 | striatum development (GO:0021756) | 3.03381778 |
| 106 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.03178167 |
| 107 | transmission of nerve impulse (GO:0019226) | 3.01154550 |
| 108 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.00970050 |
| 109 | cellular response to prostaglandin stimulus (GO:0071379) | 3.00810749 |
| 110 | granulocyte activation (GO:0036230) | 2.99889841 |
| 111 | synaptic vesicle maturation (GO:0016188) | 2.99458439 |
| 112 | regulation of postsynaptic membrane potential (GO:0060078) | 2.99049976 |
| 113 | relaxation of smooth muscle (GO:0044557) | 2.97918254 |
| 114 | regulation of blood coagulation (GO:0030193) | 2.96013806 |
| 115 | regulation of hemostasis (GO:1900046) | 2.96013806 |
| 116 | negative regulation of heart contraction (GO:0045822) | 2.95052008 |
| 117 | membrane depolarization during action potential (GO:0086010) | 2.94997643 |
| 118 | negative regulation of adherens junction organization (GO:1903392) | 2.93102692 |
| 119 | negative regulation of focal adhesion assembly (GO:0051895) | 2.93102692 |
| 120 | negative regulation of cell junction assembly (GO:1901889) | 2.93102692 |
| 121 | urinary tract smooth muscle contraction (GO:0014848) | 2.93027533 |
| 122 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.92102221 |
| 123 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.89789100 |
| 124 | synaptic transmission (GO:0007268) | 2.87764047 |
| 125 | regulation of protein kinase A signaling (GO:0010738) | 2.87588950 |
| 126 | desmosome organization (GO:0002934) | 2.86949333 |
| 127 | extracellular fibril organization (GO:0043206) | 2.85936812 |
| 128 | vesicle targeting (GO:0006903) | 2.85494067 |
| 129 | regulation of receptor recycling (GO:0001919) | 2.85313589 |
| 130 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.84692182 |
| 131 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.84635798 |
| 132 | positive regulation of synapse assembly (GO:0051965) | 2.84520872 |
| 133 | membrane depolarization (GO:0051899) | 2.84454157 |
| 134 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.83388092 |
| 135 | behavioral response to pain (GO:0048266) | 2.82496435 |
| 136 | synapse assembly (GO:0007416) | 2.80929525 |
| 137 | exploration behavior (GO:0035640) | 2.80512443 |
| 138 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.80294579 |
| 139 | fatty acid elongation (GO:0030497) | 2.79573632 |
| 140 | locomotory exploration behavior (GO:0035641) | 2.79429422 |
| 141 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79033854 |
| 142 | regulation of protein localization to plasma membrane (GO:1903076) | 2.78078875 |
| 143 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.77957968 |
| 144 | beta-amyloid metabolic process (GO:0050435) | 2.77874848 |
| 145 | regulation of female receptivity (GO:0045924) | 2.76562454 |
| 146 | regulation of glutamate secretion (GO:0014048) | 2.76318770 |
| 147 | regulation of neurotransmitter levels (GO:0001505) | 2.75461160 |
| 148 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.75333259 |
| 149 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.75333259 |
| 150 | calcium ion-dependent exocytosis (GO:0017156) | 2.75112784 |
| 151 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.74862736 |
| 152 | regulation of neurotransmitter secretion (GO:0046928) | 2.74823074 |
| 153 | negative regulation of heart rate (GO:0010459) | 2.74277560 |
| 154 | action potential (GO:0001508) | 2.74174827 |
| 155 | positive regulation of membrane potential (GO:0045838) | 2.73203674 |
| 156 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.73178595 |
| 157 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.72134055 |
| 158 | long-term memory (GO:0007616) | 2.71637635 |
| 159 | positive regulation of amino acid transport (GO:0051957) | 2.71368457 |
| 160 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.71343062 |
| 161 | regulation of coagulation (GO:0050818) | 2.70943829 |
| 162 | female mating behavior (GO:0060180) | 2.70650406 |
| 163 | intraspecies interaction between organisms (GO:0051703) | 2.70346828 |
| 164 | social behavior (GO:0035176) | 2.70346828 |
| 165 | positive regulation of cell junction assembly (GO:1901890) | 2.69282211 |
| 166 | positive regulation of focal adhesion assembly (GO:0051894) | 2.69282211 |
| 167 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.68989273 |
| 168 | learning (GO:0007612) | 2.67359242 |
| 169 | purinergic receptor signaling pathway (GO:0035587) | 2.67288958 |
| 170 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.67286781 |
| 171 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.66711208 |
| 172 | synaptic vesicle endocytosis (GO:0048488) | 2.66214488 |
| 173 | regulation of synaptic plasticity (GO:0048167) | 2.66118857 |
| 174 | membrane hyperpolarization (GO:0060081) | 2.65232272 |
| 175 | behavioral response to cocaine (GO:0048148) | 2.64761286 |
| 176 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.64101506 |
| 177 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.63951186 |
| 178 | regulation of neurotransmitter transport (GO:0051588) | 2.62508852 |
| 179 | leukocyte tethering or rolling (GO:0050901) | 2.62118022 |
| 180 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.61961316 |
| 181 | positive regulation of synaptic transmission (GO:0050806) | 2.61588727 |
| 182 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.61587273 |
| 183 | behavioral defense response (GO:0002209) | 2.60207711 |
| 184 | behavioral fear response (GO:0001662) | 2.60207711 |
| 185 | positive regulation of muscle hypertrophy (GO:0014742) | 2.59462963 |
| 186 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.59462963 |
| 187 | glycosphingolipid biosynthetic process (GO:0006688) | 2.58711904 |
| 188 | regulation of memory T cell differentiation (GO:0043380) | 2.58349215 |
| 189 | righting reflex (GO:0060013) | 2.58227648 |
| 190 | regulation of early endosome to late endosome transport (GO:2000641) | 2.57498138 |
| 191 | positive regulation of leukocyte degranulation (GO:0043302) | 2.57014916 |
| 192 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.56111250 |
| 193 | endothelium development (GO:0003158) | 2.55766565 |
| 194 | activation of protein kinase A activity (GO:0034199) | 2.55599060 |
| 195 | fibrinolysis (GO:0042730) | 2.55577156 |
| 196 | fibril organization (GO:0097435) | 2.55401251 |
| 197 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.54659527 |
| 198 | positive regulation of granulocyte differentiation (GO:0030854) | 2.52882949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.71788432 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.20896489 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.52172289 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.41181792 |
| 5 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.36618839 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.27358648 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89841725 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.84947808 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.75599129 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.70792310 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58204722 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55274942 |
| 13 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.52030613 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40725434 |
| 15 | GATA1_19941826_ChIP-Seq_K562_Human | 2.40707619 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37397609 |
| 17 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.35317436 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.34879090 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.33948043 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31663154 |
| 21 | GATA2_19941826_ChIP-Seq_K562_Human | 2.27202070 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.26538113 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21343398 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21343398 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20889349 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19724129 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.17418351 |
| 28 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13427868 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13123866 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.12317611 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.09680005 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 2.09478617 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08915250 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.08197060 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.08022586 |
| 36 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07803580 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.06960907 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 2.04832689 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04743005 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.99119430 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.98751430 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96769521 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94716703 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84290248 |
| 45 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.84211332 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.82417681 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81513668 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79894520 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79742677 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.78730795 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.78730795 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.78441222 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76558516 |
| 54 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73867102 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.73838071 |
| 56 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73365414 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72827505 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71523927 |
| 59 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.71359578 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70974555 |
| 61 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69462648 |
| 62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.67998929 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67556072 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65265992 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64392211 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63801643 |
| 67 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.62496306 |
| 68 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.61989959 |
| 69 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.61989959 |
| 70 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60964226 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58630186 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58168768 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.57464958 |
| 74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57147523 |
| 75 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.56784580 |
| 76 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56582760 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53367332 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.52993011 |
| 79 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.52901299 |
| 80 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.50798380 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49913285 |
| 82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.49586138 |
| 83 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49489782 |
| 84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48699944 |
| 85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.46573909 |
| 86 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46322212 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46284156 |
| 88 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45500766 |
| 89 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.45481936 |
| 90 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.43433892 |
| 91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42729141 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42409837 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.39312776 |
| 94 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.38572916 |
| 95 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38196051 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.38059465 |
| 97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37675303 |
| 98 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.36459163 |
| 99 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35408685 |
| 100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34488181 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34198339 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33676344 |
| 103 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33657469 |
| 104 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33426919 |
| 105 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31842284 |
| 106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31730597 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.30733780 |
| 108 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.30517708 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29083255 |
| 110 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28985187 |
| 111 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28358567 |
| 112 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27000029 |
| 113 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26823316 |
| 114 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26645546 |
| 115 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25517339 |
| 116 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24660451 |
| 117 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24134819 |
| 118 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22835320 |
| 119 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22073959 |
| 120 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.21684023 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21666909 |
| 122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20891953 |
| 123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19254962 |
| 124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.19209764 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19179555 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18865470 |
| 127 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16963481 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16857534 |
| 129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16455341 |
| 130 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16451182 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16047057 |
| 132 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15824563 |
| 133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15670719 |
| 134 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15541113 |
| 135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15397808 |
| 136 | * JUN_21703547_ChIP-Seq_K562_Human | 1.15178912 |
| 137 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14770122 |
| 138 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14574435 |
| 139 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14050870 |
| 140 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13995863 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13915971 |
| 142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13764050 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13494443 |
| 144 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11510272 |
| 145 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11478107 |
| 146 | KDM2B_26808549_Chip-Seq_REH_Human | 1.11006792 |
| 147 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10364638 |
| 148 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10118168 |
| 149 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.09870854 |
| 150 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09094418 |
| 151 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08683748 |
| 152 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07323136 |
| 153 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06767401 |
| 154 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06187575 |
| 155 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05205676 |
| 156 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04980770 |
| 157 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04818030 |
| 158 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04755493 |
| 159 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03747096 |
| 160 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03516335 |
| 161 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03041281 |
| 162 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02247220 |
| 163 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02068969 |
| 164 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01697755 |
| 165 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00973868 |
| 166 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99940224 |
| 167 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99703597 |
| 168 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99395856 |
| 169 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99395856 |
| 170 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98663574 |
| 171 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98445068 |
| 172 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98445068 |
| 173 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98412827 |
| 174 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98207669 |
| 175 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97862043 |
| 176 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96719597 |
| 177 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94908287 |
| 178 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89089610 |
| 179 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88892963 |
| 180 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87764588 |
| 181 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85006569 |
| 182 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.84116520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005464_abnormal_platelet_physiology | 7.65912594 |
| 2 | MP0001968_abnormal_touch/_nociception | 4.77471223 |
| 3 | MP0002736_abnormal_nociception_after | 4.72382533 |
| 4 | MP0003880_abnormal_central_pattern | 4.51001154 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.95983952 |
| 6 | MP0002735_abnormal_chemical_nociception | 3.70156204 |
| 7 | MP0000465_gastrointestinal_hemorrhage | 3.54855612 |
| 8 | MP0003566_abnormal_cell_adhesion | 3.32965043 |
| 9 | MP0003724_increased_susceptibility_to | 3.20854841 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.19706853 |
| 11 | MP0009745_abnormal_behavioral_response | 3.14397297 |
| 12 | MP0008004_abnormal_stomach_pH | 2.94990775 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.85951721 |
| 14 | MP0002064_seizures | 2.75472630 |
| 15 | MP0009046_muscle_twitch | 2.70348172 |
| 16 | MP0001986_abnormal_taste_sensitivity | 2.68955224 |
| 17 | MP0004270_analgesia | 2.62318314 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.61944397 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.61659214 |
| 20 | MP0001188_hyperpigmentation | 2.54971436 |
| 21 | MP0002272_abnormal_nervous_system | 2.51836931 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.50328819 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.49932234 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.45329191 |
| 25 | MP0001970_abnormal_pain_threshold | 2.42109337 |
| 26 | MP0002796_impaired_skin_barrier | 2.36567016 |
| 27 | MP0004510_myositis | 2.29028834 |
| 28 | MP0005083_abnormal_biliary_tract | 2.28783138 |
| 29 | MP0004084_abnormal_cardiac_muscle | 2.18149448 |
| 30 | MP0010386_abnormal_urinary_bladder | 2.16491268 |
| 31 | MP0002822_catalepsy | 2.14242839 |
| 32 | MP0005501_abnormal_skin_physiology | 2.10501349 |
| 33 | MP0005646_abnormal_pituitary_gland | 2.10370743 |
| 34 | MP0004947_skin_inflammation | 2.04932840 |
| 35 | MP0002067_abnormal_sensory_capabilities | 2.00010545 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.99372581 |
| 37 | MP0001851_eye_inflammation | 1.99100571 |
| 38 | MP0001486_abnormal_startle_reflex | 1.96228767 |
| 39 | MP0003828_pulmonary_edema | 1.95287464 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.95263476 |
| 41 | MP0000343_altered_response_to | 1.93213896 |
| 42 | MP0001664_abnormal_digestion | 1.92924055 |
| 43 | MP0001984_abnormal_olfaction | 1.86228767 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.85978535 |
| 45 | MP0003122_maternal_imprinting | 1.83908661 |
| 46 | MP0005275_abnormal_skin_tensile | 1.81459259 |
| 47 | MP0003787_abnormal_imprinting | 1.79170362 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.74388468 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.74064665 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.73700949 |
| 51 | MP0000383_abnormal_hair_follicle | 1.71195709 |
| 52 | MP0002876_abnormal_thyroid_physiology | 1.66001557 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.65071296 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.63261241 |
| 55 | MP0002184_abnormal_innervation | 1.60262007 |
| 56 | MP0010678_abnormal_skin_adnexa | 1.56996920 |
| 57 | MP0001905_abnormal_dopamine_level | 1.56897011 |
| 58 | MP0001529_abnormal_vocalization | 1.56660345 |
| 59 | MP0003091_abnormal_cell_migration | 1.55457060 |
| 60 | MP0000579_abnormal_nail_morphology | 1.54490085 |
| 61 | MP0005023_abnormal_wound_healing | 1.53291253 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.52013923 |
| 63 | MP0004924_abnormal_behavior | 1.51899677 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.51899677 |
| 65 | MP0000230_abnormal_systemic_arterial | 1.51314976 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.50238776 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 1.48487832 |
| 68 | MP0000858_altered_metastatic_potential | 1.47226869 |
| 69 | MP0004036_abnormal_muscle_relaxation | 1.46475590 |
| 70 | MP0004142_abnormal_muscle_tone | 1.43206910 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 1.41991939 |
| 72 | MP0001835_abnormal_antigen_presentation | 1.33247059 |
| 73 | MP0003303_peritoneal_inflammation | 1.32913615 |
| 74 | MP0005058_abnormal_lysosome_morphology | 1.31657203 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 1.29500467 |
| 76 | MP0010234_abnormal_vibrissa_follicle | 1.25166202 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 1.24766906 |
| 78 | MP0000249_abnormal_blood_vessel | 1.23807726 |
| 79 | MP0004130_abnormal_muscle_cell | 1.23276181 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 1.22835553 |
| 81 | MP0008775_abnormal_heart_ventricle | 1.22628321 |
| 82 | MP0008569_lethality_at_weaning | 1.19250323 |
| 83 | MP0001216_abnormal_epidermal_layer | 1.18015152 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 1.17943575 |
| 85 | MP0004858_abnormal_nervous_system | 1.16782312 |
| 86 | MP0005409_darkened_coat_color | 1.14717749 |
| 87 | MP0005165_increased_susceptibility_to | 1.14699191 |
| 88 | MP0000778_abnormal_nervous_system | 1.12973494 |
| 89 | MP0005410_abnormal_fertilization | 1.08347052 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 1.07239575 |
| 91 | MP0002909_abnormal_adrenal_gland | 1.06804749 |
| 92 | MP0004811_abnormal_neuron_physiology | 1.06587151 |
| 93 | MP0001765_abnormal_ion_homeostasis | 1.05346172 |
| 94 | MP0003879_abnormal_hair_cell | 1.04659582 |
| 95 | MP0001849_ear_inflammation | 1.03459379 |
| 96 | MP0008872_abnormal_physiological_respon | 1.02889306 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.99464528 |
| 98 | MP0002882_abnormal_neuron_morphology | 0.99243529 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 0.99077286 |
| 100 | MP0001663_abnormal_digestive_system | 0.96598380 |
| 101 | MP0004484_altered_response_of | 0.96337549 |
| 102 | MP0009763_increased_sensitivity_to | 0.95773191 |
| 103 | MP0000538_abnormal_urinary_bladder | 0.95522858 |
| 104 | MP0008260_abnormal_autophagy | 0.94043850 |
| 105 | MP0003866_abnormal_defecation | 0.93928102 |
| 106 | MP0001502_abnormal_circadian_rhythm | 0.93701258 |
| 107 | * MP0002398_abnormal_bone_marrow | 0.93696690 |
| 108 | MP0002009_preneoplasia | 0.92796959 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.92278913 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.92012105 |
| 111 | MP0006054_spinal_hemorrhage | 0.91584013 |
| 112 | MP0003329_amyloid_beta_deposits | 0.91028764 |
| 113 | MP0004381_abnormal_hair_follicle | 0.90738947 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.90427929 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.89354031 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.89354031 |
| 117 | MP0002163_abnormal_gland_morphology | 0.89322468 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.89052236 |
| 119 | MP0003705_abnormal_hypodermis_morpholog | 0.87154960 |
| 120 | MP0000955_abnormal_spinal_cord | 0.87151138 |
| 121 | MP0003436_decreased_susceptibility_to | 0.85853019 |
| 122 | MP0005394_taste/olfaction_phenotype | 0.85461834 |
| 123 | MP0005499_abnormal_olfactory_system | 0.85461834 |
| 124 | MP0001963_abnormal_hearing_physiology | 0.84536964 |
| 125 | MP0001177_atelectasis | 0.83563086 |
| 126 | MP0005164_abnormal_response_to | 0.82149434 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.82053895 |
| 128 | MP0003763_abnormal_thymus_physiology | 0.80641498 |
| 129 | MP0001191_abnormal_skin_condition | 0.79930222 |
| 130 | MP0006138_congestive_heart_failure | 0.79894713 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.79360971 |
| 132 | MP0004883_abnormal_blood_vessel | 0.78899406 |
| 133 | MP0004147_increased_porphyrin_level | 0.78832233 |
| 134 | MP0005379_endocrine/exocrine_gland_phen | 0.78555867 |
| 135 | MP0005621_abnormal_cell_physiology | 0.77287324 |
| 136 | MP0000569_abnormal_digit_pigmentation | 0.76728293 |
| 137 | MP0000681_abnormal_thyroid_gland | 0.76722286 |
| 138 | MP0004742_abnormal_vestibular_system | 0.76061450 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.76052282 |
| 140 | MP0003633_abnormal_nervous_system | 0.74177126 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.71420675 |
| 142 | MP0002166_altered_tumor_susceptibility | 0.71080075 |
| 143 | MP0002098_abnormal_vibrissa_morphology | 0.70892840 |
| 144 | MP0009931_abnormal_skin_appearance | 0.70785709 |
| 145 | MP0000377_abnormal_hair_follicle | 0.70475133 |
| 146 | MP0005535_abnormal_body_temperature | 0.70321770 |
| 147 | MP0003448_altered_tumor_morphology | 0.69772677 |
| 148 | MP0008874_decreased_physiological_sensi | 0.69286774 |
| 149 | MP0004782_abnormal_surfactant_physiolog | 0.67574893 |
| 150 | MP0000427_abnormal_hair_cycle | 0.67245024 |
| 151 | MP0002229_neurodegeneration | 0.66794081 |
| 152 | MP0010329_abnormal_lipoprotein_level | 0.66471779 |
| 153 | MP0009379_abnormal_foot_pigmentation | 0.66361709 |
| 154 | MP0000467_abnormal_esophagus_morphology | 0.66198648 |
| 155 | MP0004185_abnormal_adipocyte_glucose | 0.66047520 |
| 156 | MP0005310_abnormal_salivary_gland | 0.65705178 |
| 157 | MP0000631_abnormal_neuroendocrine_gland | 0.65112715 |
| 158 | MP0000516_abnormal_urinary_system | 0.65044170 |
| 159 | MP0005367_renal/urinary_system_phenotyp | 0.65044170 |
| 160 | MP0005084_abnormal_gallbladder_morpholo | 0.64686730 |
| 161 | MP0004134_abnormal_chest_morphology | 0.64415083 |
| 162 | MP0002277_abnormal_respiratory_mucosa | 0.64201613 |
| 163 | MP0005381_digestive/alimentary_phenotyp | 0.63684719 |
| 164 | MP0002060_abnormal_skin_morphology | 0.63252868 |
| 165 | MP0000627_abnormal_mammary_gland | 0.62877036 |
| 166 | MP0002128_abnormal_blood_circulation | 0.62875990 |
| 167 | MP0000372_irregular_coat_pigmentation | 0.62457763 |
| 168 | MP0003950_abnormal_plasma_membrane | 0.62184569 |
| 169 | MP0001270_distended_abdomen | 0.61792479 |
| 170 | MP0009697_abnormal_copulation | 0.60805042 |
| 171 | MP0003638_abnormal_response/metabolism_ | 0.59303214 |
| 172 | MP0002752_abnormal_somatic_nervous | 0.58757613 |
| 173 | MP0003631_nervous_system_phenotype | 0.58743716 |
| 174 | MP0010771_integument_phenotype | 0.57274663 |
| 175 | MP0003121_genomic_imprinting | 0.56695615 |
| 176 | MP0002638_abnormal_pupillary_reflex | 0.56308206 |
| 177 | MP0000026_abnormal_inner_ear | 0.56298889 |
| 178 | MP0004085_abnormal_heartbeat | 0.56277666 |
| 179 | MP0001943_abnormal_respiration | 0.54927929 |
| 180 | MP0000566_synostosis | 0.53621256 |
| 181 | MP0002152_abnormal_brain_morphology | 0.52774019 |
| 182 | MP0000751_myopathy | 0.52683201 |
| 183 | MP0008789_abnormal_olfactory_epithelium | 0.50247753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.45179714 |
| 2 | Increased mean platelet volume (HP:0011877) | 9.32248170 |
| 3 | Menorrhagia (HP:0000132) | 9.07117752 |
| 4 | Abnormal platelet volume (HP:0011876) | 8.70912262 |
| 5 | Focal motor seizures (HP:0011153) | 7.89032515 |
| 6 | Petechiae (HP:0000967) | 7.88153916 |
| 7 | Purpura (HP:0000979) | 6.87861840 |
| 8 | Epistaxis (HP:0000421) | 6.43281250 |
| 9 | Gingival bleeding (HP:0000225) | 6.34727078 |
| 10 | Impaired platelet aggregation (HP:0003540) | 5.50540629 |
| 11 | Abnormal platelet function (HP:0011869) | 5.50540629 |
| 12 | Febrile seizures (HP:0002373) | 5.46864731 |
| 13 | Atonic seizures (HP:0010819) | 5.46744598 |
| 14 | Focal seizures (HP:0007359) | 4.94079332 |
| 15 | Epileptic encephalopathy (HP:0200134) | 4.47317134 |
| 16 | Abnormal hair whorl (HP:0010721) | 4.35865022 |
| 17 | Myokymia (HP:0002411) | 4.17846696 |
| 18 | Absence seizures (HP:0002121) | 4.11435214 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.90313219 |
| 20 | Visual hallucinations (HP:0002367) | 3.84872909 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.76888211 |
| 22 | Acanthocytosis (HP:0001927) | 3.66473626 |
| 23 | Dialeptic seizures (HP:0011146) | 3.59806617 |
| 24 | Poikilocytosis (HP:0004447) | 3.56297880 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 3.55774072 |
| 26 | Dyschromatopsia (HP:0007641) | 3.50422181 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.49495883 |
| 28 | Hyperventilation (HP:0002883) | 3.47302272 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.36080333 |
| 30 | Hypothermia (HP:0002045) | 3.34236662 |
| 31 | Papillary thyroid carcinoma (HP:0002895) | 3.31589892 |
| 32 | Bruising susceptibility (HP:0000978) | 3.29625535 |
| 33 | Failure to thrive in infancy (HP:0001531) | 3.11734028 |
| 34 | Conjunctival telangiectasia (HP:0000524) | 3.05652197 |
| 35 | Gait imbalance (HP:0002141) | 3.04328550 |
| 36 | Progressive inability to walk (HP:0002505) | 3.03000693 |
| 37 | Anxiety (HP:0000739) | 2.89900584 |
| 38 | Congenital primary aphakia (HP:0007707) | 2.87692553 |
| 39 | Broad-based gait (HP:0002136) | 2.78819852 |
| 40 | Polyphagia (HP:0002591) | 2.78499867 |
| 41 | Termporal pattern (HP:0011008) | 2.75827897 |
| 42 | Insidious onset (HP:0003587) | 2.75827897 |
| 43 | Acute necrotizing encephalopathy (HP:0006965) | 2.73969426 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.72306786 |
| 45 | Progressive macrocephaly (HP:0004481) | 2.69036753 |
| 46 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.67491037 |
| 47 | Nephrogenic diabetes insipidus (HP:0009806) | 2.67241923 |
| 48 | Abnormal auditory evoked potentials (HP:0006958) | 2.66962194 |
| 49 | Genital tract atresia (HP:0001827) | 2.56090230 |
| 50 | Poor suck (HP:0002033) | 2.53731978 |
| 51 | Drooling (HP:0002307) | 2.53181856 |
| 52 | Excessive salivation (HP:0003781) | 2.53181856 |
| 53 | Pheochromocytoma (HP:0002666) | 2.52443741 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.46711115 |
| 55 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.46711115 |
| 56 | Amblyopia (HP:0000646) | 2.44903694 |
| 57 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44456747 |
| 58 | Inability to walk (HP:0002540) | 2.43405913 |
| 59 | Esotropia (HP:0000565) | 2.41424951 |
| 60 | Narrow nasal bridge (HP:0000446) | 2.40384017 |
| 61 | Abnormal eating behavior (HP:0100738) | 2.39336825 |
| 62 | Neuroendocrine neoplasm (HP:0100634) | 2.37742658 |
| 63 | Limb dystonia (HP:0002451) | 2.37198497 |
| 64 | Vaginal atresia (HP:0000148) | 2.36742491 |
| 65 | Thick nail (HP:0001805) | 2.35609667 |
| 66 | Mitochondrial inheritance (HP:0001427) | 2.31581280 |
| 67 | Gaze-evoked nystagmus (HP:0000640) | 2.30152648 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.30075537 |
| 69 | Diplopia (HP:0000651) | 2.28689503 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.28689503 |
| 71 | Abnormal pupillary function (HP:0007686) | 2.27789553 |
| 72 | Generalized hypopigmentation of hair (HP:0011358) | 2.27521528 |
| 73 | Specific learning disability (HP:0001328) | 2.26657218 |
| 74 | Hypoventilation (HP:0002791) | 2.23623480 |
| 75 | Abnormal ciliary motility (HP:0012262) | 2.21560082 |
| 76 | Oligomenorrhea (HP:0000876) | 2.19658269 |
| 77 | Mitral stenosis (HP:0001718) | 2.18782186 |
| 78 | Thyroid carcinoma (HP:0002890) | 2.18708472 |
| 79 | Abnormality of pain sensation (HP:0010832) | 2.18693594 |
| 80 | Impaired pain sensation (HP:0007328) | 2.18693594 |
| 81 | Abnormality of nail color (HP:0100643) | 2.18124358 |
| 82 | Fetal akinesia sequence (HP:0001989) | 2.16662408 |
| 83 | Truncal ataxia (HP:0002078) | 2.15496645 |
| 84 | Erythema (HP:0010783) | 2.15096827 |
| 85 | Protruding tongue (HP:0010808) | 2.15069797 |
| 86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.14789158 |
| 87 | Absent/shortened dynein arms (HP:0200106) | 2.14789158 |
| 88 | Sleep apnea (HP:0010535) | 2.14560796 |
| 89 | Ankyloglossia (HP:0010296) | 2.13701081 |
| 90 | Upper limb muscle weakness (HP:0003484) | 2.12511964 |
| 91 | Aortic aneurysm (HP:0004942) | 2.11492813 |
| 92 | Curly hair (HP:0002212) | 2.09326109 |
| 93 | Vascular calcification (HP:0004934) | 2.07381151 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 2.05895673 |
| 95 | Poor coordination (HP:0002370) | 2.05777474 |
| 96 | Abnormality of salivation (HP:0100755) | 2.04959328 |
| 97 | Cardiovascular calcification (HP:0011915) | 2.03852473 |
| 98 | Blue irides (HP:0000635) | 2.03469758 |
| 99 | Joint swelling (HP:0001386) | 2.03138520 |
| 100 | Fair hair (HP:0002286) | 2.01759619 |
| 101 | Bradycardia (HP:0001662) | 2.01269702 |
| 102 | Psychosis (HP:0000709) | 2.00780611 |
| 103 | Absent speech (HP:0001344) | 2.00159393 |
| 104 | Male infertility (HP:0003251) | 1.99758678 |
| 105 | Hyperthyroidism (HP:0000836) | 1.99315930 |
| 106 | Epileptiform EEG discharges (HP:0011182) | 1.99271420 |
| 107 | Abnormality of the labia minora (HP:0012880) | 1.95486799 |
| 108 | Increased density of long bones (HP:0006392) | 1.95196457 |
| 109 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.94825780 |
| 110 | Arterial thrombosis (HP:0004420) | 1.92213427 |
| 111 | Scanning speech (HP:0002168) | 1.90307085 |
| 112 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.88821998 |
| 113 | Eczematoid dermatitis (HP:0000976) | 1.87293333 |
| 114 | Tetraparesis (HP:0002273) | 1.84629002 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.83502421 |
| 116 | Uterine leiomyosarcoma (HP:0002891) | 1.83153104 |
| 117 | Leiomyosarcoma (HP:0100243) | 1.83153104 |
| 118 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.82689659 |
| 119 | Poor eye contact (HP:0000817) | 1.82586334 |
| 120 | Labial hypoplasia (HP:0000066) | 1.82554312 |
| 121 | Back pain (HP:0003418) | 1.82425504 |
| 122 | Acute encephalopathy (HP:0006846) | 1.81798578 |
| 123 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.81555512 |
| 124 | Paralysis (HP:0003470) | 1.80267613 |
| 125 | Abnormality of oral frenula (HP:0000190) | 1.80201423 |
| 126 | Testicular neoplasm (HP:0010788) | 1.80019680 |
| 127 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79551803 |
| 128 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79551803 |
| 129 | Spontaneous abortion (HP:0005268) | 1.78941609 |
| 130 | Dyskinesia (HP:0100660) | 1.78052535 |
| 131 | Severe short stature (HP:0003510) | 1.77740813 |
| 132 | Alopecia of scalp (HP:0002293) | 1.77136394 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 1.76278908 |
| 134 | EEG with generalized epileptiform discharges (HP:0011198) | 1.75782540 |
| 135 | Optic disc pallor (HP:0000543) | 1.75766144 |
| 136 | Right ventricular cardiomyopathy (HP:0011663) | 1.75271429 |
| 137 | Increased CSF lactate (HP:0002490) | 1.74075046 |
| 138 | Depression (HP:0000716) | 1.73932992 |
| 139 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.72636775 |
| 140 | Ulnar claw (HP:0001178) | 1.72043470 |
| 141 | Cerebral inclusion bodies (HP:0100314) | 1.71399537 |
| 142 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.70959946 |
| 143 | Action tremor (HP:0002345) | 1.69957706 |
| 144 | Short tibia (HP:0005736) | 1.69716584 |
| 145 | Pancreatic fibrosis (HP:0100732) | 1.69503453 |
| 146 | Biliary tract neoplasm (HP:0100574) | 1.67170290 |
| 147 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.67146383 |
| 148 | Heterochromia iridis (HP:0001100) | 1.67033088 |
| 149 | Hepatocellular necrosis (HP:0001404) | 1.66434739 |
| 150 | Bladder carcinoma (HP:0002862) | 1.66418187 |
| 151 | Bladder neoplasm (HP:0009725) | 1.66418187 |
| 152 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.66243187 |
| 153 | Joint hemorrhage (HP:0005261) | 1.66041857 |
| 154 | Ventricular fibrillation (HP:0001663) | 1.66023932 |
| 155 | Milia (HP:0001056) | 1.65417035 |
| 156 | Autoamputation (HP:0001218) | 1.65088459 |
| 157 | Plantar hyperkeratosis (HP:0007556) | 1.64639755 |
| 158 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.64516290 |
| 159 | Dysautonomia (HP:0002459) | 1.64442214 |
| 160 | Palmoplantar hyperkeratosis (HP:0000972) | 1.61827192 |
| 161 | Ankle clonus (HP:0011448) | 1.61378217 |
| 162 | X-linked dominant inheritance (HP:0001423) | 1.60980747 |
| 163 | Thrombocytosis (HP:0001894) | 1.60900175 |
| 164 | Impaired social interactions (HP:0000735) | 1.60880121 |
| 165 | Abnormal social behavior (HP:0012433) | 1.60880121 |
| 166 | Abnormality of iron homeostasis (HP:0011031) | 1.60583568 |
| 167 | Onycholysis (HP:0001806) | 1.60305339 |
| 168 | Akinesia (HP:0002304) | 1.59937529 |
| 169 | Choroideremia (HP:0001139) | 1.59703958 |
| 170 | Renal tubular acidosis (HP:0001947) | 1.59376488 |
| 171 | Exotropia (HP:0000577) | 1.58130049 |
| 172 | Inappropriate behavior (HP:0000719) | 1.58113245 |
| 173 | Abnormality of incisor morphology (HP:0011063) | 1.58074161 |
| 174 | Dysmetria (HP:0001310) | 1.57340174 |
| 175 | Aortic dissection (HP:0002647) | 1.55596268 |
| 176 | Abnormality of macrophages (HP:0004311) | 1.55550388 |
| 177 | Nail dystrophy (HP:0008404) | 1.55471112 |
| 178 | Xanthomatosis (HP:0000991) | 1.54645094 |
| 179 | Tinnitus (HP:0000360) | 1.54503469 |
| 180 | Abnormality of the Achilles tendon (HP:0005109) | 1.50787950 |
| 181 | Absent frontal sinuses (HP:0002688) | 1.50240799 |
| 182 | Palmar hyperkeratosis (HP:0010765) | 1.49739106 |
| 183 | Decreased central vision (HP:0007663) | 1.49693481 |
| 184 | Increased IgE level (HP:0003212) | 1.49413335 |
| 185 | Myocardial infarction (HP:0001658) | 1.49065575 |
| 186 | Hepatosplenomegaly (HP:0001433) | 1.47343880 |
| 187 | Distal lower limb muscle weakness (HP:0009053) | 1.45958042 |
| 188 | Hyporeflexia of lower limbs (HP:0002600) | 1.45665619 |
| 189 | Arterial tortuosity (HP:0005116) | 1.42789413 |
| 190 | Glomerulosclerosis (HP:0000096) | 1.42319414 |
| 191 | Chest pain (HP:0100749) | 1.40691467 |
| 192 | Tongue fasciculations (HP:0001308) | 1.39546611 |
| 193 | Coarse hair (HP:0002208) | 1.39359766 |
| 194 | Dysostosis multiplex (HP:0000943) | 1.39285526 |
| 195 | Papilledema (HP:0001085) | 1.38405081 |
| 196 | Ridged nail (HP:0001807) | 1.38144400 |
| 197 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.38032395 |
| 198 | Polycythemia (HP:0001901) | 1.37714372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.75361339 |
| 2 | NTRK3 | 4.16567978 |
| 3 | CASK | 3.91226371 |
| 4 | BMX | 3.29161544 |
| 5 | EPHA4 | 3.16123826 |
| 6 | MAP2K7 | 3.06142422 |
| 7 | RIPK4 | 2.90382286 |
| 8 | MAP3K4 | 2.72427303 |
| 9 | EIF2AK1 | 2.59509146 |
| 10 | EPHA2 | 2.51274358 |
| 11 | MAP3K9 | 2.44243554 |
| 12 | TEC | 2.40163526 |
| 13 | BTK | 2.32465547 |
| 14 | FRK | 2.29980679 |
| 15 | PIK3CG | 2.13145782 |
| 16 | NME1 | 2.10984203 |
| 17 | MINK1 | 1.95178833 |
| 18 | ZAP70 | 1.92983339 |
| 19 | MAP2K4 | 1.91955111 |
| 20 | TAOK3 | 1.87423155 |
| 21 | MST1R | 1.86223818 |
| 22 | GRK5 | 1.83638522 |
| 23 | STK3 | 1.79383559 |
| 24 | GRK6 | 1.74318791 |
| 25 | SCYL2 | 1.72977322 |
| 26 | CSF1R | 1.71566528 |
| 27 | TNIK | 1.71097215 |
| 28 | MST4 | 1.67450828 |
| 29 | ARAF | 1.65139580 |
| 30 | SYK | 1.62602569 |
| 31 | TNK2 | 1.60725937 |
| 32 | PLK2 | 1.55282179 |
| 33 | AKT3 | 1.54516534 |
| 34 | ILK | 1.51923833 |
| 35 | DAPK2 | 1.51298968 |
| 36 | DAPK1 | 1.50495796 |
| 37 | MAPKAPK3 | 1.49822829 |
| 38 | BMPR2 | 1.39381825 |
| 39 | MET | 1.35145105 |
| 40 | MUSK | 1.32021366 |
| 41 | NTRK1 | 1.31692727 |
| 42 | MAPK13 | 1.31358695 |
| 43 | IRAK3 | 1.31350510 |
| 44 | FER | 1.31279882 |
| 45 | PDGFRB | 1.31201560 |
| 46 | HCK | 1.27363886 |
| 47 | MAPKAPK5 | 1.26053792 |
| 48 | TSSK6 | 1.26043053 |
| 49 | BMPR1B | 1.24511404 |
| 50 | MAP3K6 | 1.22581257 |
| 51 | NTRK2 | 1.19337783 |
| 52 | MYLK | 1.19337780 |
| 53 | MAP3K2 | 1.18363603 |
| 54 | SGK2 | 1.14624484 |
| 55 | CDK19 | 1.14465807 |
| 56 | CAMK2A | 1.13519406 |
| 57 | EPHB1 | 1.13140530 |
| 58 | ADRBK2 | 1.09363276 |
| 59 | JAK1 | 1.07671411 |
| 60 | KSR2 | 1.06793859 |
| 61 | OXSR1 | 1.05776757 |
| 62 | FGR | 1.03932268 |
| 63 | PRKCE | 1.02628498 |
| 64 | MARK1 | 1.01275392 |
| 65 | FES | 1.00117565 |
| 66 | CDK5 | 0.99599532 |
| 67 | EPHA3 | 0.98795243 |
| 68 | SIK3 | 0.98675276 |
| 69 | LMTK2 | 0.96527888 |
| 70 | GRK7 | 0.93429556 |
| 71 | PRKCG | 0.92052554 |
| 72 | PDPK1 | 0.91446443 |
| 73 | PDK1 | 0.90036479 |
| 74 | PTK2 | 0.85773521 |
| 75 | MATK | 0.84907427 |
| 76 | SGK223 | 0.84842019 |
| 77 | SGK494 | 0.84842019 |
| 78 | IRAK1 | 0.83962239 |
| 79 | MAP2K3 | 0.83446658 |
| 80 | MAP2K1 | 0.83364557 |
| 81 | TRIM28 | 0.82280923 |
| 82 | ERBB4 | 0.80491629 |
| 83 | CAMK2B | 0.80010273 |
| 84 | MAP3K13 | 0.78169204 |
| 85 | PKN2 | 0.77904897 |
| 86 | PDGFRA | 0.77857967 |
| 87 | PNCK | 0.77705632 |
| 88 | CCNB1 | 0.77641594 |
| 89 | MAP3K3 | 0.77099932 |
| 90 | MAP3K5 | 0.74401647 |
| 91 | KSR1 | 0.74159000 |
| 92 | RPS6KA2 | 0.71820870 |
| 93 | PIK3CA | 0.71461915 |
| 94 | PAK1 | 0.68745194 |
| 95 | CAMK2D | 0.67826889 |
| 96 | YES1 | 0.66848918 |
| 97 | NEK6 | 0.64007295 |
| 98 | ERBB3 | 0.63925007 |
| 99 | CAMK1G | 0.62313545 |
| 100 | ERBB2 | 0.62255735 |
| 101 | CSK | 0.61961279 |
| 102 | SIK1 | 0.60553551 |
| 103 | ACVR1B | 0.59667667 |
| 104 | RAF1 | 0.59101747 |
| 105 | PAK2 | 0.58054878 |
| 106 | BCR | 0.57827111 |
| 107 | CDK8 | 0.57112631 |
| 108 | CSNK1G2 | 0.56875804 |
| 109 | SGK1 | 0.56574553 |
| 110 | JAK3 | 0.54930498 |
| 111 | JAK2 | 0.54766449 |
| 112 | IKBKB | 0.54628532 |
| 113 | SGK3 | 0.54544429 |
| 114 | MAP3K1 | 0.53036516 |
| 115 | LATS1 | 0.52747006 |
| 116 | FLT3 | 0.52514330 |
| 117 | CDK3 | 0.52461171 |
| 118 | PRPF4B | 0.52439372 |
| 119 | STK16 | 0.52014431 |
| 120 | STK24 | 0.51142336 |
| 121 | ADRBK1 | 0.51071365 |
| 122 | PRKD1 | 0.50170737 |
| 123 | STK39 | 0.49353401 |
| 124 | TAOK1 | 0.47997304 |
| 125 | TIE1 | 0.47825484 |
| 126 | PTK2B | 0.47617072 |
| 127 | MAP2K6 | 0.47571436 |
| 128 | ITK | 0.47430290 |
| 129 | FYN | 0.46579034 |
| 130 | BRSK2 | 0.46165063 |
| 131 | CAMKK2 | 0.45693509 |
| 132 | BRAF | 0.45401945 |
| 133 | CAMK2G | 0.45317500 |
| 134 | PRKACA | 0.45278763 |
| 135 | PINK1 | 0.45174686 |
| 136 | TAOK2 | 0.44754213 |
| 137 | PAK3 | 0.43295702 |
| 138 | IRAK2 | 0.43157261 |
| 139 | PDK2 | 0.43075908 |
| 140 | DAPK3 | 0.41378499 |
| 141 | LYN | 0.41175305 |
| 142 | PRKG2 | 0.40507754 |
| 143 | PRKCA | 0.39391155 |
| 144 | HIPK2 | 0.39106407 |
| 145 | CAMKK1 | 0.38835299 |
| 146 | STK38 | 0.37762891 |
| 147 | RPS6KB1 | 0.37392658 |
| 148 | PAK6 | 0.36796956 |
| 149 | PRKG1 | 0.35515300 |
| 150 | FGFR2 | 0.35045468 |
| 151 | FGFR3 | 0.34950998 |
| 152 | GRK1 | 0.34776998 |
| 153 | MKNK2 | 0.34621290 |
| 154 | NEK9 | 0.34395050 |
| 155 | TRPM7 | 0.33244133 |
| 156 | CDK14 | 0.33125487 |
| 157 | CAMK1 | 0.31418429 |
| 158 | DYRK1A | 0.30331438 |
| 159 | TRIB3 | 0.30330302 |
| 160 | PRKACG | 0.30302782 |
| 161 | RET | 0.30160140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.08053499 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.24051812 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.15840335 |
| 4 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.71181439 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69051646 |
| 6 | Taste transduction_Homo sapiens_hsa04742 | 2.48215395 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.47187628 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.41604504 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.24063818 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.21995065 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.20273870 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.12747699 |
| 13 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.12291253 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.10660672 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.08734757 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.07913004 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 2.04852973 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.02233479 |
| 19 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.93619241 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.86084887 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.83590779 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.79416709 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.78813102 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.66545822 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.65331998 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64471747 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64313422 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.61602557 |
| 29 | * Pancreatic secretion_Homo sapiens_hsa04972 | 1.58245708 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47494140 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.43290476 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.42954863 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41224957 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41036747 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.40642184 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.35679860 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.35492486 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.35440966 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34738897 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33743961 |
| 41 | Endocytosis_Homo sapiens_hsa04144 | 1.32949602 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.32550839 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32478245 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32234472 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31034224 |
| 46 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.30544644 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30124142 |
| 48 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.28702752 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25345019 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.25042604 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22890021 |
| 52 | Endometrial cancer_Homo sapiens_hsa05213 | 1.22149575 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21990738 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.19813499 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.19067214 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18782220 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17871504 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 1.13346974 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13236759 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11671470 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04637059 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04564849 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04088991 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 1.02367246 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01479307 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00568873 |
| 67 | Adherens junction_Homo sapiens_hsa04520 | 1.00220641 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.99894496 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99526294 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99088736 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.98211622 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96351863 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94204455 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93946156 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92639598 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91617307 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90589432 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89978015 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89526526 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87791668 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85026136 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.83952144 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82871070 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82800453 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82638194 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75957435 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75520248 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75487970 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74711029 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73158887 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72056707 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71271719 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69102929 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68900987 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67338682 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65941904 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65869868 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65770851 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65330589 |
| 100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64644754 |
| 101 | Malaria_Homo sapiens_hsa05144 | 0.64024892 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.63580824 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62009075 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.60656719 |
| 105 | Axon guidance_Homo sapiens_hsa04360 | 0.59347359 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58241587 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.57802432 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.56004267 |
| 109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54976124 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.54974119 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.54260717 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53779970 |
| 113 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53742311 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53289801 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51903654 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49193095 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48991273 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46161484 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.45707709 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45579656 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45285161 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45278378 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44927388 |
| 124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44732928 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44288567 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43841577 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43755976 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43644406 |
| 129 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43252307 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42020556 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36942674 |
| 132 | Melanoma_Homo sapiens_hsa05218 | 0.36808244 |
| 133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36237504 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.35994771 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34731599 |
| 136 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33759789 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33266354 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32233985 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31399071 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30959917 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30728767 |
| 142 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26626910 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25029940 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24350216 |
| 145 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24286112 |
| 146 | Alcoholism_Homo sapiens_hsa05034 | 0.23762079 |
| 147 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23526342 |
| 148 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.21773919 |
| 149 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20856527 |
| 150 | Salmonella infection_Homo sapiens_hsa05132 | 0.18404612 |
| 151 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14095121 |
| 152 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13486745 |
| 153 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.13088078 |

